The former Director of China's State Food and Drug Administration, Zheng Xiaoyu, was executed on July 10, after the country's Supreme Court endorsed the sentence which was passed for taking nearly 6.5 million renminbi ($853,000) in bribes and dereliction of duty (Marketletters June 4 and 18). Mr Zheng had pleaded guilty to both charges.
Although the disgraced former drug regulator offered information after his conviction, in an attempt to have his sentence reduced, the Supreme Court stated that no new evidence had been provided to prosecutors.
A spokeswoman for the SFDA responded to the news of Me Zheng's death and the announcement that one of his deputies, Cao Wenzhuang (who headed the agency's drug registration department), had received a suspended death sentence (Marketletter July 16). Yan Jiangying said: "we should seriously reflect and learn lessons from these cases."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze